In AD transgenic mice that overexpress mutant APP, excess levels of this full-length APP may occupy most of BACE1 enzymatic activity, thus leading to a decrease in its capacity to process other substrates, including proteins that regulate ion channel function and ultimately neuronal excitability. Here, BACE1 is linked to Alzheimer disease.